deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT03258281

Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus (ISS-DMII)

Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus After Elective Percutaneous Coronary Intervention

Sponsor: Inova Health Care Services

Conditions Diabetes Mellitus, Type 2 Dyslipidemia Associated With Type II Diabetes Mellitus Percutaneous Coronary Intervention
Interventions Evolocumab Placebo
Updated 12 times since 2017 Last updated: Dec 22, 2022 Started: May 1, 2018 Primary completion: Sep 1, 2019 Completion: Oct 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low enrollment

Other terminated trials from Inova Health Care Services

See all terminations from Inova Health Care Services

Other Diabetes Mellitus, Type 2 trials with similar outcome

Browse all Diabetes Mellitus, Type 2 trials

Listed as NCT03258281, this PHASE4 trial focuses on Diabetes Mellitus, Type 2 and Dyslipidemia Associated With Type II Diabetes Mellitus and remains terminated or withdrawn. Sponsored by Inova Health Care Services, it has been updated 12 times since 2018, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Sep 2017 – ~Feb 2018 · 5 months · monthly snapshotNot Yet Recruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Mar 2019 · 6 months · monthly snapshotRecruiting~Mar 2019 – ~Nov 2019 · 8 months · monthly snapshotRecruiting~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotTerminated~Jan 2021 – ~Feb 2022 · 13 months · monthly snapshotTerminated~Feb 2022 – ~Apr 2022 · 59 days · monthly snapshotTerminated~Apr 2022 – ~Feb 2023 · 10 months · monthly snapshotTerminated~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Feb 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Apr 2022 — Feb 2023 [monthly]

    Terminated PHASE4

  5. Feb 2022 — Apr 2022 [monthly]

    Terminated PHASE4

▶ Show 7 earlier versions

  1. Jan 2021 — Feb 2022 [monthly]

    Terminated PHASE4

  2. Nov 2019 — Jan 2021 [monthly]

    Terminated PHASE4

    Status: Recruiting → Terminated · Phase: EARLY_PHASE1 → PHASE4

  3. Mar 2019 — Nov 2019 [monthly]

    Recruiting EARLY_PHASE1

  4. Sep 2018 — Mar 2019 [monthly]

    Recruiting EARLY_PHASE1

  5. Jun 2018 — Sep 2018 [monthly]

    Recruiting EARLY_PHASE1

  6. Feb 2018 — Jun 2018 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  7. Sep 2017 — Feb 2018 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Inova Health Care Services
Data source: Inova Health Care Services

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations